全科医生与药师协作状况评估问卷的跨文化调适与信效度检验

李万超; 蔡松涛; 严明; 陆益婷; 邓志玲; 卢盼攀; 李海昕; 徐志杰

doi:10.16766/j.cnki.issn.1674-4152.003556

全科医生与药师协作状况评估问卷的跨文化调适与信效度检验

doi: 10.16766/j.cnki.issn.1674-4152.003556

1.
长兴县林城镇卫生院，浙江湖州 313100
2.
深圳市龙岗区人民医院全科医学科，广东深圳 518172
3.
浙江大学医学院附属邵逸夫医院全科医学科，浙江杭州 310016
4.
同济大学医学院全科医学系，上海 200092
5.
中山大学附属第八医院荔村区域社康中心，广东深圳 518033
6.
台州市立医院全科医学科，浙江台州 318000
7.
西安交通大学第一附属医院药学部，陕西西安 710061
8.
浙江大学医学院附属第二医院全科医学科，浙江杭州 310009

基金项目:

浙江省医药卫生科技计划项目 2023KY748

浙江省医药卫生科技计划项目 2024KY1026

详细信息

通讯作者:
徐志杰，E-mail：zhijiexu@zju.edu.cn

中图分类号: R197.61R192.9
计量
- 文章访问数: 35
- HTML全文浏览量: 16
- PDF下载量: 3
- 被引次数: 0
出版历程
- 收稿日期: 2023-10-09
- 网络出版日期: 2024-07-22

Cross-cultural adaptation, reliability and validity of GP-pharmacist collaboration assessment questionnaire

1.
Lincheng Healthcare Center of Changxing County, Huzhou, Zhejiang 313100, China

摘要

摘要: 目的全科医生与药师的协作是影响患者医疗质量的重要因素。全科医生对与药师协作的态度及协作频率评估问卷(ATCI-GP和FICI-GP)是分别用于评估全科医生对协作的态度和参与协作频率的科学工具，但该问卷尚未经过汉化。本研究将ATCI-GP与FICI-GP分别经过跨文化调适成为中文版问卷，并检验中文版问卷的信度和效度，旨在为评估全科医生与药师协作状况提供研究工具。方法本研究遵循跨文化调适指南和Brislin翻译原则，将ATCI-GP和FICI-GP跨文化调适为中文版问卷C-ATCI-GP、C-FICI-GP。采用方便抽样法，于2022年11月—2023年2月选取深圳市、杭州市、西安市、长沙市和北京市的25家基层卫生机构的全科医生进行调查，以分析该问卷的信度和效度。结果共回收问卷346份，其中有效问卷320份。C-ATCI-GP的整体Cronbach's α系数为0.958，C-FICI-G的整体Cronbach’s α系数为0.967。两份问卷所有条目的|CR值|均＞3.000(P＜0.001)，各条目得分与量表总分的相关系数＞0.300(P＜0.001)。C-ATCI-GP的内容效度指数(S-CVI)为0.876。C-FICI-GP的内容效度指数(S-CVI)为0.882。结构效度分析显示，C-ATCI-GP共提取出2个公因子，累计方差贡献率达到了72.546%；C-FICI-GP共提取出1个公因子，方差贡献率为77.713%。结论经过本研究跨文化调适的C-ATCI-GP和C-FICI-GP具有良好的信度和效度，可作为国内研究者评估全科医生对与药师协作的态度与频率状况的可靠调查工具。
- 全科医生 /
- 药师 /
- 跨文化调适 /
- 信效度
Abstract: Objective The collaboration between pharmacists and general practitioners (GPs) is essential to the quality of patient care. Attitudes toward collaboration instrument for GPs (ATCI-GP) and frequency of interprofessional collaboration instrument for GPs (FICI-GP) have been used to assess GPs' attitudes towards collaboration with pharmacists and their frequency of collaboration, respectively, yet they had not been validated in the Chinese version. To provide a research tool for assessing the collaboration between GPs and pharmacists, we translate ATCI-GP and FICI-GP into Chinese and test the reliability and validity of the Chinese version. Methods Following the guidelines for cross-cultural adaptation and the Brislin translation principle, the ATCI-GP and FICI-GP were translated into Chinese versions of questionnaires C-ATCI-GP and C-FICI-GP. From December 2022 to February 2023, a survey was conducted among general practitioners from 25 primary health institutions in Shenzhen, Hangzhou, Xi' an, Changsha, and Beijing to analyze the reliability and validity of the questionnaire by convenience sampling method. Results A total of 346 questionnaires were collected, of which 320 were valid. The overall Cronbach' s α coefficient for C-ATCI-GP was 0.958, and for C-FICI-G, it was 0.967. The |CR values| for all items in both questionnaires were greater than 3.000 (P < 0.001), and the correlation coefficients between item scores and the total scale score were greater than 0.300 (P < 0.001). The content validity index (S-CVI) for C-ATCI-GP was 0.876, and for C-FICI-GP, it was 0.882. The construct validity analysis showed that C-ATCI-GP extracted 2 common factors, accounting for a cumulative variance contribution rate of 72.546%, and C-FICI-GP extracted 1 common factor, accounting for a variance contribution rate of 77.713%. Conclusion The Chinese versions of ATCI and FICI have good reliability and validity and can be used as reliable evaluation tools for domestic researchers to evaluate the attitude and frequency of general practitioners towards collaboration with pharmacists.
- General practitioner /
- Pharmacists /
- Cross-cultural adaptation /
- Reliability and validity

HTML全文

表 1 全科医生与药师协作状况评估问卷项目分析结果

Table 1. Item analysis of the Chinese version of GP-pharmacist assessment questionnaire

问卷条目	得分(x ± s，分)	条目鉴别度		条目得分与总分相关性
问卷条目	得分(x ± s，分)	CR值	P值	r值	P值
ATCI-GP
1.我与药师在专业内容上的沟通是开诚布公的	4.41±0.72	-7.000	< 0.001	0.442	< 0.001
2.药师愿意与我一起管理患者的用药	4.29±0.67	-11.417	< 0.001	0.734	< 0.001
3.药师为患者提供了高质量的医疗健康服务	4.13±0.82	-11.810	< 0.001	0.761	< 0.001
4.药师有时间与我讨论有关患者用药方案的事宜	4.02±0.92	-10.121	< 0.001	0.739	< 0.001
5.药师的专业能力符合我对他(她)的期望	4.14±0.82	-10.477	< 0.001	0.732	< 0.001
6.我可以相信药师做出的专业决策	4.11±0.82	-7.760	< 0.001	0.672	< 0.001
7.药师积极地解决患者的用药问题	4.20±0.75	-12.587	< 0.001	0.758	< 0.001
8.药师和我在专业层面上互相尊重	4.42±0.63	-10.128	< 0.001	0.719	< 0.001
9.药师和我在治疗患者方面有共同的目标	4.46±0.62	-9.376	< 0.001	0.678	< 0.001
10.我和药师在患者治疗上的职责分工是明确的	4.30±0.74	-10.191	< 0.001	0.781	< 0.001
11.我信任药师在药物治疗方面的专业性	4.33±0.69	-10.152	< 0.001	0.752	< 0.001
12.药师在确保用药安全方面发挥了作用(例如，识别药物相互作用、不良反应、禁忌证等)	4.31±0.65	-12.805	< 0.001	0.764	< 0.001
13.药师在确保药物有效性方面发挥了作用(例如，确保患者获得最合适的药物且剂量合理等)	4.30±0.65	-14.186	< 0.001	0.772	< 0.001
FICI-GP
1.我和药师彼此坦诚地沟通交流	2.90±0.96	-12.818	< 0.001	0.734	< 0.001
2.药师向我告知可使用的新药物或他们可以提供的服务	2.87±1.00	-15.851	< 0.001	0.818	< 0.001
3.我联系药师了解具体的药物信息	2.89±0.93	-14.489	< 0.001	0.824	< 0.001
4.我向药师了解患者的具体信息	2.68±1.10	-14.040	< 0.001	0.827	< 0.001
5.药师向我确认处方的内容	3.11±0.92	-9.727	< 0.001	0.698	< 0.001
6.药师联系我讨论药物剂量的调整	2.79±0.99	-9.751	< 0.001	0.764	< 0.001
7.药师向我推荐了替代药物(例如，由于不良反应、禁忌证等)	2.64±1.10	-14.530	< 0.001	0.815	< 0.001
8.我在药师的建议下调整了患者的用药	2.60±1.00	-12.800	< 0.001	0.804	< 0.001
9.我向药师分享了患者信息	2.72±1.10	-14.119	< 0.001	0.780	< 0.001
10.我让药师参与有关用药管理的决策	2.69±1.00	-17.440	< 0.001	0.845	< 0.001
注：CR值=决断值。

下载: 导出CSV

表 2 全科医生与药师协作状况评估问卷各条目的因子载荷值

Table 2. The factor loading values for every item in the Chinese version of GP-pharmacist assessment questionnaire

问卷条目	公因子
问卷条目	公因子1	公因子2
ATCI-GP
11.我信任药师在药物治疗方面的专业性	0.865	-
7.药师积极地解决患者的用药问题	0.855	-
13.药师在确保药物有效性方面发挥了作用(例如，确保患者获得最合适的药物且剂量合理等)	0.850	-
5.药师的专业能力符合我对他(她)的期望	0.834	-
12.药师在确保用药安全方面发挥了作用(例如，识别药物相互作用、不良反应、禁忌证等)	0.833	-
3.药师为患者提供了高质量的医疗健康服务	0.828	-
6.我可以相信药师做出的专业决策	0.807	-
10.我和药师在患者治疗上的职责分工是明确的	0.802	-
4.药师有时间与我讨论有关患者用药方案的事宜	0.789	-
1.我与药师在专业内容上的沟通是开诚布公的	-	0.840
8.药师和我在专业层面上互相尊重	-	0.737
9.药师和我在治疗患者方面有共同的目标	-	0.704
2.药师愿意与我一起管理患者的用药	-	0.655
FICI-GP
7.药师向我推荐了替代药物(例如，由于不良反应、禁忌证等)	0.914
10.我让药师参与有关用药管理的决策	0.913
9.我向药师分享了患者信息	0.907
8.我在药师的建议下调整了患者的用药	0.902
4.我向药师了解患者的具体信息	0.900
6.药师联系我讨论药物剂量的调整	0.888
3.我联系药师了解具体的药物信息	0.884
1.我和药师彼此坦诚地沟通交流	0.833
2.药师向我告知可使用的新药物或他们可以提供的服务	0.832
5.药师向我确认处方的内容	0.804
注：“- ”表示在此公因子上的载荷值< 0.500。

下载: 导出CSV

参考文献(19)

[1]	KWAK M J, CHENG M, GOYAL P, et al. Medication complexity among older adults with HF: how can we assess better?[J]. Drugs Aging, 2022, 39(11): 851-861. doi: 10.1007/s40266-022-00979-2
[2]	TURK A, WONG G, MAHTANI K R, et al. Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review[J]. BMC Med, 2022, 20(1): 297. doi: 10.1186/s12916-022-02475-1
[3]	张亚琳, 廖晓阳, 赵茜, 等. 基层整合型医疗服务的国际经验和中国实践[J]. 中华全科医学, 2021, 19(6): 887-891. doi: 10.16766/j.cnki.issn.1674-4152.001942 ZHANG Y L, LIAO X Y, ZHAO Q, et al. International experience and practice of integrated primary care in China[J]. Chinese Journal of General Practice, 2021, 19(6): 887-891. doi: 10.16766/j.cnki.issn.1674-4152.001942
[4]	NI X F, YANG C S, BAI Y M, et al. Drug-related problems of patients in primary health care institutions: a systematic review[J]. Front Pharmacol, 2021, 12: 698907. DOI: 10.3389/fphar.2021.698907.
[5]	韩悦, 杨振华, 韩庆烽, 等. 多病共存患者认知功能的管理现状[J]. 中华全科医学, 2023, 21(8): 1388-1392. doi: 10.16766/j.cnki.issn.1674-4152.003129 HAN Y, YANG Z H, HAN Q F, et al. Current status of management of cognitive function in patients with multimorbidity[J]. Chinese Journal of General Practice, 2023, 21(8): 1388-1392. doi: 10.16766/j.cnki.issn.1674-4152.003129
[6]	邓志玲, 陆益婷, 梁旭健, 等. 基层药师与全科医生团队合作的研究进展、挑战及应对策略[J]. 中国全科医学, 2023, 26(10): 1179-1185. doi: 10.12114/j.issn.1007-9572.2022.0615 DENG Z L, LU Y T, LIANG X J, et al. Collaboration between Primary Care Pharmacists and General Practitioner Teams: Recent Developments, Challenges and Countermeasures[J]. Chinese General Practice, 2023, 26(10): 1179-1185. doi: 10.12114/j.issn.1007-9572.2022.0615
[7]	HASAN IBRAHIM A S, BARRY H E, HUGHES C M. GPs' and pharmacists' views of integrating pharmacists into general practices: a qualitative study[J]. Br J Gen Pract, 2023, 73(731): e407-e417. doi: 10.3399/BJGP.2022.0518
[8]	TRENAMAN S C, KENNIE-KAULBACH N, D' ENTREMONT-MACVICAR E, et al. Implementation of pharmacist-led deprescribing in collaborative primary care settings[J]. Int J Clin Pharm, 2022, 44(5): 1216-1221. doi: 10.1007/s11096-022-01449-w
[9]	RAHAYU S A, WIDIANTO S, DEFI I R, et al. Role of pharmacists in the interprofessional care team for patients with chronic diseases[J]. J Multidiscip Healthc, 2021, 14: 1701-1710. doi: 10.2147/JMDH.S309938
[10]	CLAIRE M, CLAIRE A, MATTHEW B. The role of clinical pharmacists in general practice in England: impact, perspectives, barriers and facilitators[J]. Res Social Adm Pharm, 2022, 18(8): 3432-3437. doi: 10.1016/j.sapharm.2021.10.006
[11]	KARAMPATAKIS G D, PATEL N, STRETCH G, et al. Integration and impact of pharmacists in general practice internationally: a rapid review[J]. J Health Serv Res Policy, 2024, 29(1): 56-67. doi: 10.1177/13558196231179831
[12]	ALSHEHRI A A, CHEEMA E, YAHYOUCHE A, et al. Evaluating the role and integration of general practice pharmacists in England: a cross-sectional study[J]. Int J Clin Pharm, 2021, 43(6): 1609-1618. doi: 10.1007/s11096-021-01291-6
[13]	CAI S T, HUANG X H, VAN C, et al. General practitioners' attitudes towards and frequency of collaboration with pharmacists in China: a cross-sectional study[J]. BMC Health Serv Res, 2023, 23(1): 1174. doi: 10.1186/s12913-023-10151-0
[14]	SUDESHIKA T, DEEKS L S, NAUNTON M, et al. Interprofessional collaboration within general practice teams following the inclusion of non-dispensing pharmacists[J]. J Pharm Policy Pract, 2023, 16(1): 49. doi: 10.1186/s40545-023-00550-3
[15]	WEISSENBORN M, KRASS I, VAN C, et al. Process of translation and cross-cultural adaptation of two Australian instruments to evaluate the physician-pharmacist collaboration in Germany[J]. Res Social Adm Pharm, 2020, 16(1): 74-83. doi: 10.1016/j.sapharm.2019.03.009
[16]	BEATON D E, BOMBARDIER C, GUILLEMIN F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures[J]. Spine (Phila Pa 1976), 2000, 25(24): 3186-3191. doi: 10.1097/00007632-200012150-00014
[17]	YAO M, XU B P, TIAN Z R, et al. Cross-cultural adaptation of the neck pain and disability scale: a methodological systematic review[J]. Spine J, 2019, 19(6): 1057-1066. doi: 10.1016/j.spinee.2019.01.007
[18]	黄雪梅, 徐晓媛, 杨帅, 等. 国外医师与药师协作关系测量工具介绍及对我国的启示[J]. 中国药事, 2020, 34(10): 1200-1208. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYS202010012.htm HUANG X M, XU X Y, YANG S, et al. A Review of Instruments for physician-Pharmacist Collaboration Abroad and Its Enlightenment to China[J]. Chinese Pharmaceutical Affairs, 2020, 34(10): 1200-1208. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYS202010012.htm
[19]	GRAEFF M D S, ALMEIDA M A, PORCEL-GÁLVEZ A M, et al. Cross-cultural adaptation and validation of instrument to measure nursing care dependency[J]. Rev Gaucha Enferm, 2022, 43: e20210135. DOI: 10.1590/1983-1447.2022.20210135.en.